Denali Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Denali Advisors's GILD Position: Q4 2019 in Review
Denali Advisors sold out of Gilead Sciences (GILD) in Q4 2019, closing a stake of 162,703 shares — an estimated $10.3M sold.
Denali Advisors first reported a position in GILD in Q1 2016 and held it in 15 quarters. The position peaked at $14.1M in Q3 2016. 1,555 funds tracked by Wall St. Rank hold GILD as of Q4 2019.
- Denali Advisors reported no remaining Gilead Sciences position as of Q4 2019 after selling out during the quarter.
- Denali Advisors sold 162,703 Gilead Sciences shares in Q4 2019, an estimated $10.3M.
- Denali Advisors first reported a position in Gilead Sciences in Q1 2016 and held it in 15 quarters.
- Denali Advisors's Gilead Sciences position peaked at $14.1M in Q3 2016.
- 1,555 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2019.
Based on Denali Advisors's 13F filing for Q4 2019, filed 30 Jan 2020.